Axil Brands vs Solesence
Solesence is the larger business, with $62.1m of revenue in fiscal 2025 against $30.8m for Axil Brands (2.0 times as much). Solesence grew faster (18.6% against 17.5%). Axil Brands kept more of each dollar of sales as profit: a net margin of 8.8% against 2.9%. Axil Brands carries less debt relative to equity (1.1% against 101.3%).
| Latest fiscal year | Axil BrandsAXIL, 2026 | SolesenceSLSN, 2025 |
|---|---|---|
| Revenue | $30.8m | $62.1m |
| Revenue growth | 17.5% | 18.6% |
| Net income | $2.7m | $1.8m |
| Operating margin | 9.7% | 2.5% |
| Net margin | 8.8% | 2.9% |
| Return on equity | 23.7% | 14.6% |
| Free cash flow | −$89,020 | −$8.6m |
| Cash | $4.5m | $1.3m |
| Total debt | $142,864 | $14.3m |
| Debt to equity | 1.1% | 101.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 115 |
| Market value | $39.4m | $61.0m |
| Price vs our value range | Above our value range | — |
| Moat score | 36 (Weak) | 30 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 7 buys, 0 sales |